Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 3Active not recruiting 2Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Giant Cell Tumor of Tendon Sheath 3Synovitis, Pigmented Villonodular 2Neoplasm Metastasis 2Melanoma 2Gastrointestinal Stromal Tumors 2Stage I Prostate Adenocarcinoma 1Solid Tumors 1Solid Tumor 1Recurrence 1Pancreatic Neoplasms 1Neoplasms 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Glioblastoma 1Colorectal Neoplasms 1Breast Neoplasms 1Advanced Solid Tumors 1

Interventions

pexidartinib 3nilotinib 1cabiralizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Giant Cell Tumor of Tendon Sheath × pexidartinib × Clear all
NCT04526704 2024-12-30

PLX3397

Daiichi Sankyo

Phase 4 Completed
32 enrolled 15 charts

Giant Cell Tumor of Tendon Sheath

NCT02371369 2022-05-11

ENLIVEN

Daiichi Sankyo

Phase 3 Completed
120 enrolled 25 charts 1 FDA

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT04223635 2021-06-22

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Daiichi Sankyo

Phase EARLY_PHASE1 Completed
16 enrolled 22 charts

Giant Cell Tumor of Tendon Sheath

Data powered by HemOnc (CC BY 4.0) Colophon âš¡